…in my style of investing, I don't assign probabilities.
I do not understand what you mean. Are you suggesting that MNTA’s winning the Copaxone patent case is a sure thing so that no number-crunching on your part is necessary? If so, I would submit that such a viewpoint is misguided.
If you don’t think a MNTA win in the patent case is a sure thing, then you must have some probabilities in mind, whether or not you chose to reveal them.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”